(Reuters) -U.S. President Donald Trump will sign an executive order on Monday to streamline regulations surrounding pharmaceutical manufacturing in the United States, the Washington Post reported, citing two White House officials.

President Donald Trump signed an executive order to encourage domestic prescription drug manufacturing and cut down on the time it takes to approve U.S. pharmaceutical plants.

President Donald Trump signed an executive order to incentivize drug manufacturing in the U.S. The order comes ahead of Trump's planned tariffs on pharmaceuticals imported into the U.S. U.S. production in the pharmaceutical industry has shrunk significantly in recent decades due to lower costs for labor and other parts of the process in countries like China and some European nations.